This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Circulation: CardiovascularImaging, Ahead of Print. in 2022, followed by single-photon emission computed tomography (CT) myocardial perfusion imaging, which decreased from 20.8% in 2022, followed by single-photon emission computed tomography (CT) myocardial perfusion imaging, which decreased from 20.8% to 12.9%.
These foundational advancements set the stage for Lauterbur and Mansfield’s work in the 1970s, which integrated proton-resonant frequency differences to produce images reflective of tissue characteristics. The third stage, beginning in 2010 and continuing today, emphasized the widespread clinical use of CMR.
According to an abstract issued by the Journal of Cardiovascular Computed Tomography (JCCT), cardiac CT continues to expand with increasing applications and evolving technology. It reported the rate of CCTA exams by radiologists in hospital outpatient departments increased markedly from 2010 to 2019. Reeves, MD, Ethan J.
Circulation: CardiovascularImaging, Volume 16, Issue 12 , Page e015671, December 1, 2023. ARVC prevalence by 2010 ARVC Revised Task Force Criteria is 91/109 (83%) and 83/99 (84%) in those with RV strain measurements. BACKGROUND:Imaging evaluation of arrhythmogenic right ventricular cardiomyopathy (ARVC) remains challenging.
Circulation: CardiovascularImaging, Ahead of Print. BACKGROUND:Immune checkpoint inhibitors (ICIs), though revolutionary in cancer treatment, may accelerate atherosclerosis by inducing arterial inflammation. Patients aged 65 years with at least 4 sequential scans within 30 months were included.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content